Longeveron Inc. Featured in Syndicated Broadcast Highlighting Top-Line Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ for the Treatment of Mild Alzheimer's tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Longeveron Announces Positive Top-Line Results for Lomecel-B™ in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer's Disease tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Stem-cell therapy delivers potential in Alzheimer's europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Wren Therapeutics announced today a number of new members to its Scientific Advisory Board. Joining existing members Tuomas Knowles, PhD; Sara.
UNLV economic analysts had some good news for us as 2021 came to a close.
Southern Nevada’s economic recovery though still linked hand in hand with the COVID-19 pandemic and its variants has a cautiously optimistic outlook as we head into the new year.